Key result
Intraoperative dexmedetomidine linked to lower incidence and severity of AKI after non-cardiac surgery.
Why the study?
Does intraoperative dexmedetomidine reduce the incidence and severity of postoperative acute kidney injury in patients undergoing non-cardiovascular surgery?
Does intraoperative dexmedetomidine reduce the incidence and severity of postoperative acute kidney injury in patients undergoing non-cardiovascular surgery?
Intraoperative dexmedetomidine is associated with a reduced incidence and severity of acute kidney injury following non-cardiac surgery, though it does not appear to impact ICU stay or mortality.
For non-cardiovascular surgery patient population, intraoperative use of dexmedetomidine was associated with a lower incidence and less severity of postoperative AKI. However, there was no significant correlation with postoperative ICU occupancy or in-hospital mortality. Further prospective RCTs are needed in the future.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2023) studied this question. Intraoperative dexmedetomidine use was associated with lower incidence and less severity of acute kidney injury after non-cardiac surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: